Iron dysregulation in movement disorders (Q37977795)

26 August 2017

title

Iron dysregulation in movement disorders (English)

1 reference

26 August 2017

2

Joseph Jankovic

1 reference

26 August 2017

1

Petr Dusek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22266337

23 December 2024

author name string

Weidong Le

3

1 reference

26 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22266337

23 December 2024

publication date

12 January 2012

1 reference

full work available at URL

26 August 2017

https://api.elsevier.com/content/article/PII:S0969996112000095?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

https://api.elsevier.com/content/article/PII:S0969996112000095?httpAccept=text/plain

23 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

published in

Neurobiology of Disease

1 reference

26 August 2017

volume

46

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

1-18

1 reference

26 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms

23 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients.

23 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The role of iron in restless legs syndrome

23 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

MRI measurement of brain iron in patients with restless legs syndrome

23 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1

23 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration

23 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms

23 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism

23 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration.

23 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders

23 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration

23 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Increased basal ganglia iron levels in Huntington disease

23 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

23 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration

23 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

23 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Friedreich's ataxia: the vicious circle hypothesis revisited

23 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron metabolism in Parkinsonian syndromes

23 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The basal ganglia in haemochromatosis

23 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Studies of human myelin proteins during old age

23 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

23 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Association study between iron-related genes polymorphisms and Parkinson's disease

23 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease

23 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype

23 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Idiopathic NBIA--clinical spectrum and transcranial sonography findings

23 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat

23 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Multiple sclerosis and the accumulation of iron in the Basal Ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry

23 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings

23 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients.

23 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis

23 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species

23 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Eye of the tiger-like MRI in parkinsonian variant of multiple system atrophy

23 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

High brain iron level in asymptomatic carriers of heterozygous ceruloplasmin gene mutations

23 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease

23 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The "eye-of-the-tiger" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration.

23 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation

23 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.

23 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Altered cellular distribution of iron in the central nervous system of myelin deficient rats

23 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

23 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Is hemochromatosis a risk factor for Alzheimer's disease?

23 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome

23 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome

23 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Profile of altered brain iron acquisition in restless legs syndrome

23 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes

23 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series

23 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy

23 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Brain iron metabolism and its perturbation in neurological diseases.

23 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

23 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM)

23 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

MR imaging findings in 2 cases of late infantile GM1 gangliosidosis

23 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy

23 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation

23 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

23 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35).

23 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel

23 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

MRI of brain iron

59

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

23 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease

23 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat.

23 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia

23 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism

23 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The “eye of the tiger” sign in pure akinesia with gait freezing

23 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population

23 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis

23 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability

23 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease

23 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease

23 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

23 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

23 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Axial motor disturbances after hypoxic lesions of the globus pallidus

23 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation

23 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Receptor-mediated transcytosis of transferrin across the blood-brain barrier

23 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation.

23 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.

23 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Restless legs syndrome in Friedreich ataxia: a polysomnographic study

23 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mucolipidosis type IV: characteristic MRI findings

23 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron as a cause of Parkinson disease - a myth or a well established hypothesis?

23 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ferritin as an important player in neurodegeneration

23 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast.

23 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hepcidin and disorders of iron metabolism

23 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Restless legs syndrome and Parkinson's disease in men

23 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron-dependent functions of mitochondria—relation to neurodegeneration

23 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

23 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Multiregional brain iron deficiency in restless legs syndrome

23 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

The Fenton reagents

92

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Redox active iron accumulation in aceruloplasminemia

23 December 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

23 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

23 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetics of Neurodegeneration with Brain Iron Accumulation

23 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neurodegeneration associated with genetic defects in phospholipase A(2).

23 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical and genetic delineation of neurodegeneration with brain iron accumulation

23 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.

23 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The effect of age on the non-haemin iron in the human brain

23 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Fatty acid 2-Hydroxylation in mammalian sphingolipid biology

23 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

23 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux

23 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation

23 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation

23 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome

23 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

DMT1 polymorphism and risk of Parkinson's disease

23 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

X-linked sideroblastic anaemia with ataxia: another mitochondrial disease?

23 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis

23 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles

23 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

23 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Movement disorders in Friedreich's ataxia

23 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic

23 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury

23 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death

23 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system

23 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Critical role of iron in the pathogenesis of the murine gangliosidoses.

23 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra

23 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease

23 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Regulation of apoptosis-associated lysosomal membrane permeabilization

23 December 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies

23 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness

23 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

23 December 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease.

23 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The PLA2G6 gene in early‐onset Parkinson's disease

23 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Brain iron metabolism: neurobiology and neurochemistry.

23 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

23 December 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

PLA2G6 mutation underlies infantile neuroaxonal dystrophy

23 December 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease

23 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins

23 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The neuropathology of late-onset Friedreich's ataxia

23 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Molecular and pathological basis of aceruloplasminemia

23 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin

23 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

23 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration

23 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations

23 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate

23 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The "eye-of-the-tiger" sign is not pathognomonic of the PANK2 mutation

23 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN).

23 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).

23 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases

23 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The role of lysosomes in iron metabolism and recycling

23 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation

23 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease

23 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation

23 December 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Group VIA Ca2 -independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death

23 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The role of iron in mitochondrial function

23 December 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron chelation and neuroprotection in neurodegenerative diseases

23 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation

23 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Increased IRP1 activity in Friedreich ataxia

23 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights

23 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement.

23 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Cognitive functioning in children with pantothenate-kinase-associated neurodegeneration undergoing deep brain stimulation

23 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations

23 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights

23 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

23 December 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Friedreich's ataxia: past, present and future

23 December 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

23 December 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide

23 December 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neurodegeneration with brain iron accumulation

23 December 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation

23 December 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The neurological presentation of ceruloplasmin gene mutations

23 December 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia

23 December 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene

23 December 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia, an iron metabolic disorder

23 December 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration

23 December 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Use of desferrioxamine in the treatment of aceruloplasminemia

23 December 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Estimation of the gene frequency of aceruloplasminemia in Japan

23 December 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation

23 December 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia, an inherited disorder of iron metabolism

23 December 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

23 December 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Histochemical distribution of non-haem iron in the human brain

23 December 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Human genetics and genomics a decade after the release of the draft sequence of the human genome

23 December 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

HFE gene variants affect iron in the brain

23 December 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

23 December 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome

23 December 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Criteria for Early Identification of Aceruloplasminemia

23 December 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene

23 December 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia

23 December 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Intravenous iron dextran for severe refractory restless legs syndrome

23 December 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States

23 December 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Fucosidosis: MRI and MRS findings

23 December 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC).

23 December 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia

23 December 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Characterization of PLA2G6 as a locus for dystonia-parkinsonism

23 December 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations

23 December 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up

23 December 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

23 December 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism

23 December 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration

23 December 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature

23 December 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus

23 December 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation

23 December 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The chemical form of mitochondrial iron in Friedreich’s ataxia

23 December 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction

23 December 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Central nervous system dysfunction in a mouse model of FA2H deficiency

23 December 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits

23 December 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Divalent metal transporter 1 is a hypoxia‐inducible gene

23 December 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.

23 December 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

23 December 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetics of iron regulation and the possible role of iron in Parkinson's disease

23 December 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

23 December 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Frataxin activates mitochondrial energy conversion and oxidative phosphorylation

23 December 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation

23 December 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review

23 December 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

23 December 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability

23 December 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex

23 December 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

High-field magnetic resonance imaging of brain iron: birth of a biomarker?

23 December 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neurodegeneration with brain iron accumulation — Clinical syndromes and neuroimaging

23 December 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Dystonia in the Woodhouse Sakati syndrome: A new family and literature review

23 December 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Three faces of the same gene: FA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias

23 December 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation

23 December 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations

23 December 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Friedreich's ataxia. Revision of the phenotype according to molecular genetics

23 December 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation

23 December 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells

23 December 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy

23 December 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hemochromatosis-induced bipolar disorder: a case report

23 December 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond

23 December 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia

23 December 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

The relevance of iron in the pathogenesis of Parkinson's disease

23 December 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease

23 December 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mitochondrial ferritin in the substantia nigra in restless legs syndrome

23 December 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Magnetic resonance imaging pattern recognition in hypomyelinating disorders

23 December 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Eye of the tiger sign in multiple system atrophy

23 December 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia

23 December 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

PLA2G6 mutations and Parkinson's disease

23 December 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein

23 December 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Developmental changes in transferrin and iron uptake by the brain in the rat.

23 December 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Role of transferrin in iron uptake by the brain: a comparative study

23 December 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration

23 December 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

23 December 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Oligodendrocytes and myelination: the role of iron

23 December 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

PLA2G6 variant in Parkinson's disease

23 December 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle

23 December 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach

23 December 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

23 December 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Hallervorden-Spatz disease: historical case presentation in the spotlight of nosological evolution

23 December 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Handedness correlates with the dominant Parkinson side: A systematic review and meta‐analysis

23 December 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Intact human ceruloplasmin is required for the incorporation of iron into human ferritin

23 December 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

23 December 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene

23 December 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Relaxation and susceptibility MRI characteristics in Hallervorden-Spatz syndrome

23 December 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content

23 December 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.

23 December 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6.

23 December 2024

253

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Mucolipidosis type IV: An update

23 December 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Increased iron in the dentate nucleus of patients with Friedrich's ataxia

23 December 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

MRI assessment of basal ganglia iron deposition in Parkinson's disease

23 December 2024

256

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease

23 December 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats

23 December 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging

23 December 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Multiple system atrophy: a primary oligodendrogliopathy.

23 December 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Intranigral injected iron progressively reduces striatal dopamine metabolism

23 December 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Fucosidosis revisited: a review of 77 patients

23 December 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Pathogenic implications of iron accumulation in multiple sclerosis

23 December 2024

263

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation

23 December 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness, and ECG abnormalities

23 December 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy.

23 December 2024

266

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells

23 December 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study

23 December 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Susceptibility contrast in high field MRI of human brain as a function of tissue iron content

23 December 2024

269

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Phenotypic spectrum of patients with PLA2G6 mutation and PARK14 -linked parkinsonism

23 December 2024

270

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

23 December 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

23 December 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit.

23 December 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation

23 December 2024

274

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases

23 December 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

23 December 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration

23 December 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

278

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2011.12.054

23 December 2024

Identifiers

1 reference

26 August 2017

1 reference